ECSP10010052A - Formulaciones galenicas de alisquireno y valsartan - Google Patents
Formulaciones galenicas de alisquireno y valsartanInfo
- Publication number
- ECSP10010052A ECSP10010052A EC2010010052A ECSP10010052A ECSP10010052A EC SP10010052 A ECSP10010052 A EC SP10010052A EC 2010010052 A EC2010010052 A EC 2010010052A EC SP10010052 A ECSP10010052 A EC SP10010052A EC SP10010052 A ECSP10010052 A EC SP10010052A
- Authority
- EC
- Ecuador
- Prior art keywords
- percent
- minutes
- valsartan
- alisquireno
- galenic formulations
- Prior art date
Links
- 239000004072 C09CA03 - Valsartan Substances 0.000 title abstract 2
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 title abstract 2
- 229960004699 valsartan Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97592507P | 2007-09-28 | 2007-09-28 | |
| US97590107P | 2007-09-28 | 2007-09-28 | |
| US97591907P | 2007-09-28 | 2007-09-28 | |
| US97590907P | 2007-09-28 | 2007-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP10010052A true ECSP10010052A (es) | 2010-04-30 |
Family
ID=40377183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2010010052A ECSP10010052A (es) | 2007-09-28 | 2010-03-26 | Formulaciones galenicas de alisquireno y valsartan |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20100209480A1 (https=) |
| EP (1) | EP2205233A2 (https=) |
| JP (1) | JP2010540547A (https=) |
| KR (1) | KR20100063090A (https=) |
| CN (1) | CN101808631A (https=) |
| AR (1) | AR066168A1 (https=) |
| AU (1) | AU2008309058B2 (https=) |
| BR (1) | BRPI0817442A2 (https=) |
| CA (1) | CA2698330A1 (https=) |
| CL (1) | CL2008002829A1 (https=) |
| CO (1) | CO6270217A2 (https=) |
| EC (1) | ECSP10010052A (https=) |
| MA (1) | MA31706B1 (https=) |
| MX (1) | MX2010003441A (https=) |
| PE (1) | PE20090654A1 (https=) |
| TN (1) | TN2010000135A1 (https=) |
| TW (1) | TW200924737A (https=) |
| WO (1) | WO2009045795A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100076996A (ko) * | 2007-09-28 | 2010-07-06 | 노파르티스 아게 | 알리스키렌의 생약 제형 |
| AR073651A1 (es) * | 2008-09-24 | 2010-11-24 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
| AR075880A1 (es) * | 2009-03-20 | 2011-05-04 | Novartis Ag | Formulaciones galenicas de compuestos organicos que comprenden alisquireno y valsartan. uso. metodo. |
| CN102361633A (zh) * | 2009-03-20 | 2012-02-22 | 诺瓦提斯公司 | 包含阿利吉仑的药物组合物 |
| WO2011116115A1 (en) * | 2010-03-16 | 2011-09-22 | Novartis Ag | Aliskiren composition comprising a medium chain fatty acid, their process of manufacturing |
| TR201002256A1 (tr) * | 2010-03-24 | 2011-10-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Stabil aliskiren formülasyonları |
| CN101926793B (zh) * | 2010-08-05 | 2012-08-15 | 成都自豪药业有限公司 | 一种含替米沙坦和阿利吉伦的联合用药物及其制备方法 |
| IN2014CN02610A (https=) * | 2011-10-12 | 2015-08-07 | Dow Global Technologies Llc | |
| MX2014007933A (es) * | 2011-12-26 | 2014-07-30 | Novartis Ag | Comprimidos y agentes recubiertos en seco. |
| CN103349652B (zh) * | 2013-05-11 | 2014-11-19 | 辽宁大学 | 含有四氢萘酰胺化合物或其可药用盐的高药物载荷片剂 |
| CN116887866A (zh) | 2020-12-03 | 2023-10-13 | 巴特尔纪念研究院 | 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法 |
| WO2022216977A1 (en) | 2021-04-07 | 2022-10-13 | Batelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| US12441996B2 (en) | 2023-12-08 | 2025-10-14 | Battelle Memorial Institute | Use of DNA origami nanostructures for molecular information based data storage systems |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
| GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
| US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
| MY148773A (en) * | 2004-03-17 | 2013-05-31 | Novartis Ag | Galenic formulations of organic compounds |
| AU2005294318A1 (en) * | 2004-10-08 | 2006-04-20 | Novartis Ag | Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
| MX2007013471A (es) * | 2005-04-27 | 2008-01-22 | Novartis Ag | Metodos de tratamiento de aterosclerosis. |
-
2008
- 2008-09-24 TW TW097136690A patent/TW200924737A/zh unknown
- 2008-09-24 KR KR1020107006603A patent/KR20100063090A/ko not_active Withdrawn
- 2008-09-24 US US12/678,877 patent/US20100209480A1/en not_active Abandoned
- 2008-09-24 WO PCT/US2008/077416 patent/WO2009045795A2/en not_active Ceased
- 2008-09-24 CA CA2698330A patent/CA2698330A1/en not_active Abandoned
- 2008-09-24 CL CL2008002829A patent/CL2008002829A1/es unknown
- 2008-09-24 MX MX2010003441A patent/MX2010003441A/es not_active Application Discontinuation
- 2008-09-24 BR BRPI0817442-3A patent/BRPI0817442A2/pt not_active IP Right Cessation
- 2008-09-24 EP EP08835022A patent/EP2205233A2/en not_active Withdrawn
- 2008-09-24 JP JP2010527091A patent/JP2010540547A/ja not_active Withdrawn
- 2008-09-24 PE PE2008001660A patent/PE20090654A1/es not_active Application Discontinuation
- 2008-09-24 AR ARP080104137A patent/AR066168A1/es not_active Application Discontinuation
- 2008-09-24 AU AU2008309058A patent/AU2008309058B2/en not_active Ceased
- 2008-09-24 CN CN200880108860A patent/CN101808631A/zh active Pending
-
2010
- 2010-03-17 MA MA32701A patent/MA31706B1/fr unknown
- 2010-03-26 TN TNP2010000135A patent/TN2010000135A1/fr unknown
- 2010-03-26 EC EC2010010052A patent/ECSP10010052A/es unknown
- 2010-04-19 CO CO10045487A patent/CO6270217A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO6270217A2 (es) | 2011-04-20 |
| MA31706B1 (fr) | 2010-09-01 |
| AR066168A1 (es) | 2009-07-29 |
| WO2009045795A3 (en) | 2009-07-16 |
| EP2205233A2 (en) | 2010-07-14 |
| US20100209480A1 (en) | 2010-08-19 |
| MX2010003441A (es) | 2010-04-21 |
| KR20100063090A (ko) | 2010-06-10 |
| BRPI0817442A2 (pt) | 2015-06-16 |
| PE20090654A1 (es) | 2009-06-27 |
| CN101808631A (zh) | 2010-08-18 |
| CA2698330A1 (en) | 2009-04-09 |
| CL2008002829A1 (es) | 2009-06-26 |
| TN2010000135A1 (en) | 2011-09-26 |
| TW200924737A (en) | 2009-06-16 |
| JP2010540547A (ja) | 2010-12-24 |
| AU2008309058B2 (en) | 2012-08-09 |
| WO2009045795A2 (en) | 2009-04-09 |
| AU2008309058A1 (en) | 2009-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010052A (es) | Formulaciones galenicas de alisquireno y valsartan | |
| ATE505203T1 (de) | Pharmazeutische kombination aus aliskiren und valsartan | |
| WO2008040534A3 (en) | Non-mucoadhesive film dosage forms | |
| MX2010002735A (es) | Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno. | |
| UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
| CA3094580A1 (en) | Oral formulations of cytidine analogs and methods of use thereof | |
| EA200901423A1 (ru) | Бензимидазолы и содержащие их фармацевтические композиции | |
| PH12014500386A1 (en) | Combination treatment for hepatitis c | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| CY1114933T1 (el) | Στερεες φαρμακευτικες συνθεσεις σταθερης δοσης περιεχουσες ιρβεσαρτανη και αμλοδιπινη, η παρασκευη τους και η θεραπευτικη εφαρμογη τους | |
| HRP20150949T1 (hr) | UPORABA 24-norUDCA | |
| PE20081106A1 (es) | Comprimidos pediatricos de capecitabina | |
| BRPI0816798A2 (pt) | composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação | |
| EP2131849A4 (en) | COMPOSITIONS AND METHODS OF DISTRIBUTING AGENTS AGAINST CANCER | |
| MX2009005798A (es) | Recuperacion de apoplejia. | |
| AR064543A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
| WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
| WO2006125194A3 (en) | Piperazine derivatives and their uses as therapeutic agents | |
| CO6351711A2 (es) | Combinacion de dosis fija en la forma de una tableta de dos copas o de una sola capa de alisquireno y amlodipina | |
| AR074246A1 (es) | Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno | |
| GT201000064A (es) | Formulaciones galénicas de alisquireno | |
| EA200801890A1 (ru) | Средство для лечения шума в ушах | |
| WO2009137436A3 (en) | Peptide conjugates | |
| UY27564A1 (es) | Combinación farmacéutica. | |
| AR062215A1 (es) | Inhibidor de trombina activo por via oral |